Strategies in the design of nanoparticles for therapeutic applications.
about
Targeted Nanotheranostics for Future Personalized Medicine: Recent Progress in Cancer TherapyTargeted Delivery Systems for Molecular Therapy in Skeletal DisordersCell Penetrating Peptide Conjugated Chitosan for Enhanced Delivery of Nucleic AcidSmart nanosystems: Bio-inspired technologies that interact with the host environmentDrug carrier interaction with blood: a critical aspect for high-efficient vascular-targeted drug delivery systemsDelivery of drugs bound to erythrocytes: new avenues for an old intravascular carrierAutoimmune therapies targeting costimulation and emerging trends in multivalent therapeuticsElucidating the mechanisms of nickel compound uptake: a review of particulate and nano-nickel endocytosis and toxicityInorganic nanosystems for therapeutic delivery: status and prospectsEnzyme-responsive nanomaterials for controlled drug deliveryNanotechnology-based drug delivery systems for treatment of oral cancer: a reviewParticle-mediated delivery of cytokines for immunotherapyNanoparticle-based monitoring of cell therapy.Co-development of diagnostic vectors to support targeted therapies and theranostics: essential tools in personalized cancer therapyDesign and application of multifunctional DNA nanocarriers for therapeutic deliveryChemical basis of interactions between engineered nanoparticles and biological systemsCan nanomedicines kill cancer stem cells?Nanotechnology in cancer therapyTargeted therapy using nanotechnology: focus on cancerMolecular imaging of atherosclerosis with nanoparticle-based fluorinated MRI contrast agentsPhotodynamic inactivation of biofilm: taking a lightly colored approach to stubborn infectionA New Concept of Enhancing Immuno-Chemotherapeutic Effects Against B16F10 Tumor via Systemic Administration by Taking Advantages of the Limitation of EPR EffectRapid Brownian Motion Primes Ultrafast Reconstruction of Intrinsically Disordered Phe-Gly Repeats Inside the Nuclear Pore Complex.Ultra-fast self-assembly and stabilization of reactive nanoparticles in reduced graphene oxide films.Direct cytosolic delivery of siRNA using nanoparticle-stabilized nanocapsulesMultivalent polymers for drug delivery and imaging: the challenges of conjugationSafety of Nanoparticles in MedicineExtracellular vesicle-mediated delivery of molecular compounds into gametes and embryos: learning from natureControlled Drug Release from Pharmaceutical NanocarriersCytokines as biomarkers of nanoparticle immunotoxicityThe Encapsulation of Hemagglutinin in Protein Bodies Achieves a Stronger Immune Response in Mice than the Soluble AntigenActivation of latent HIV using drug-loaded nanoparticlesSolvent free fabrication of micro and nanostructured drug coatings by thermal evaporation for controlled release and increased effectsPeripherally administered nanoparticles target monocytic myeloid cells, secondary lymphoid organs and tumors in miceSynthesis and biological evaluation of novel folic acid receptor-targeted, β-cyclodextrin-based drug complexes for cancer treatmentAtomic force microscopy images label-free, drug encapsulated nanoparticles in vivo and detects difference in tissue mechanical properties of treated and untreated: a tip for nanotoxicologyPeptide-mediated liposomal Doxorubicin enhances drug delivery efficiency and therapeutic efficacy in animal modelsMorphology, structure and function characterization of PEI modified magnetic nanoparticles gene delivery systemNanoformulation of D-α-tocopheryl polyethylene glycol 1000 succinate-b-poly(ε-caprolactone-ran-glycolide) diblock copolymer for siRNA targeting HIF-1α for nasopharyngeal carcinoma therapyLiposome-Cross-Linked Hybrid Hydrogels for Glutathione-Triggered Delivery of Multiple Cargo Molecules
P2860
Q26744832-4C3CC1CF-72C9-4532-B201-CC72DED41215Q26752158-6E43E0C7-60F9-4BCC-80A4-4864DD2DD17BQ26774462-E5D1D93F-189D-4B5B-920F-88A5B9B241C8Q26776370-6A484526-4368-4EB9-9B0D-FD8E4867A2D8Q26798467-9CCE6A69-AF23-4512-A97E-842B639BAC88Q26801300-FE69782B-CFC4-4B5A-95C4-C8410DB85A03Q26823789-AEB999F1-99B5-487F-B5A8-A5ED888C0C11Q26827137-50847B9E-2B45-4D5A-AFFD-06F33D8ED061Q26827968-2971135F-03FC-4988-8640-8287D898B8A4Q26992127-445984C8-47AF-460D-A985-137B998E0C2DQ26995835-928E3487-D13B-48D6-B288-891C959A57F0Q26997993-5024D314-B8DF-4B28-99E4-24346C2D0FB8Q27000646-8BBDF28D-EB8E-41EB-9587-0DE9E49A03AEQ27005742-DB123867-198C-4943-A04F-731E41D6A47CQ27007011-B74C72CA-74BA-465D-905B-E95F7FE55F69Q27021154-116BE3A4-17C2-4770-B108-D43D16D32055Q27022017-71EA5CD2-EE00-48E2-9238-045045397B01Q27023013-F71A7F52-59E0-4A97-AC56-2DD2846857EEQ27023361-E244B46D-EA1D-4EE9-8CF7-AFFC384F5608Q27027613-90DFF580-4395-48CF-936E-B316D4AB7912Q27027616-122989CE-FD38-4A8F-875D-38985415C344Q27300754-B065E578-E0AA-4DBC-9E90-BCABE6B81DA9Q27324789-B1A1CBE7-5E56-45A0-86F2-F7E5E04F24ACQ27334188-42F2542B-3421-4A5E-807F-1046763FF63EQ27339704-19F45ED8-42DF-4E68-930F-56441D662C09Q27692689-3E3560A6-3F19-4023-A6FB-7048BC6C91EAQ28083076-063A0852-AF52-48ED-B4DC-617B81DC6198Q28083833-DB7BABFC-6078-4962-8231-07408BC2D8CFQ28257050-B0C076C8-638C-46E7-BB27-50C4E9E2ECB0Q28383550-1A6FB758-F79A-4E99-B739-09806DF49840Q28387068-0DBE1836-5AAC-44D2-9218-5AA8536412DFQ28477657-ECC9284C-0C1C-47F0-8111-CBE753BACD47Q28481857-2C516F9E-37FA-4856-AA87-BF8410A0C308Q28486624-1BC99C7D-281C-4822-A658-96B9FDDF0067Q28487569-C706E281-634A-474E-AC7E-0C94B4E078C4Q28533356-1F23A9F3-F2DA-41BE-8D40-9CAF4D097936Q28538039-4056F4D7-2C71-4E27-AB59-3F1A63969ED6Q28539505-E32098BB-BDE3-419B-9DE7-C2260C3AD89BQ28649552-A09908A8-0E8B-483D-8686-8517D08F1778Q28829477-27265128-D69B-41D8-B8F1-74821E1D3C43
P2860
Strategies in the design of nanoparticles for therapeutic applications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Strategies in the design of nanoparticles for therapeutic applications.
@en
Strategies in the design of nanoparticles for therapeutic applications.
@nl
type
label
Strategies in the design of nanoparticles for therapeutic applications.
@en
Strategies in the design of nanoparticles for therapeutic applications.
@nl
prefLabel
Strategies in the design of nanoparticles for therapeutic applications.
@en
Strategies in the design of nanoparticles for therapeutic applications.
@nl
P356
P1476
Strategies in the design of nanoparticles for therapeutic applications.
@en
P2093
Joseph M DeSimone
Robby A Petros
P2888
P304
P356
10.1038/NRD2591
P577
2010-07-09T00:00:00Z